Alkermes Inc. on Friday said it raised $35 million in a publicoffering of 2 million shares of common stock at $17.50 pershare. The company, which is developing products to delivercompounds across the blood-brain barrier, has 9.6 millionshares outstanding after the offering. Underwriters Robertson,Stephens & Co. and J.P. Morgan Securities Inc. have a 300,000-share overallotment option. In July, the Cambridge, Mass.-based company netted $18 million from an initial publicoffering of 2 million shares priced at $10. The stock(NASDAQ:ALKS) closed at $18, up 38 cents, on Friday.
(c) 1997 American Health Consultants. All rights reserved.